MDxHealth SA expected to post a loss of 27 cents a share - Earnings Preview
04/11/2024 23:31
* MDxHealth SA MDXH.OQ MDXH.O is expected to show a rise
in
quarterly revenue when it reports results on November 6 for the
period ending September 30 2024
* The Herstal Liege-based company is expected to report a
11.0% increase in revenue to $21.48 million from $19.35 million
a year ago, according to the mean estimate from 6 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for MDxHealth SA is for a
loss
of 27 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 7 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for MDxHealth
SA is
$7.50, above its last closing price of $2.08.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jan. 1 0001 -0.27 -0.26 -0.42 Missed -58.5
Mar. 31 0001 -0.31 -0.30 -0.31 Missed -3.3
Jan. 1 0001 -0.22 -0.11 -0.39 Missed -254.5
Sep. 30 2023 -0.21 -0.19 -0.40 Missed -108.3
Jun. -0.25 -0.22 -0.30 Missed -37.6
30 2023
Mar. 31 2023 -0.32 -0.32 -0.50 Missed -55
Jan. 1 0001 -0.67 -0.65 -1.10 Missed -68.4
Jan. 1 0001 -0.53 -0.53 -0.50 Beat 5.1
This summary was machine generated November 4 at 23:31 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)